WSML - ETF AI Analysis
Top Page
iShares MSCI World Small-Cap ETF (WSML)
WSML vs. SPDR S&P 500 ETF (SPY)
- AUM
- 669.24M
- Region
- Developed Markets
- Expense Ratio
- 0.30%
- Beta
- 0.83
- Issuer
- iShares
- Inception Date
- Apr 01, 2025
- Dividend Yield
- 2.81%
- Asset Class
- Equity
- Index Tracked
- MSCI World Index Small Cap
WSML Summary
The iShares MSCI World Small-Cap ETF (WSML) follows the MSCI World Small Cap Index, investing in many smaller companies across developed countries, mainly the U.S., Japan, and the U.K. It spreads money across many sectors, including industrials, technology, and health care, and holds well-known names like Moderna and Roku. Investors might consider WSML if they want global diversification and the long-term growth potential of smaller, fast-growing businesses. However, small-cap stocks can be more volatile than larger companies, so the ETF’s price can move up and down more sharply with the market.
How much will it cost me?
WSML has an expense ratio of 0.30%, which means you’ll pay about $3 per year for every $1,000 invested. This cost is slightly higher than the cheapest broad stock index ETFs, but still reasonable for a passively managed fund that focuses on the more specialized small-cap segment of developed markets.
What would affect this ETF?
WSML could benefit from economic growth in developed markets, especially if innovation and demand increase in sectors like technology, health care, and industrials, supporting small companies such as Moderna, Roku, and other top holdings. On the downside, small-cap stocks are more sensitive to economic slowdowns, higher interest rates, and market volatility, and changes in health care or technology regulations could hurt key holdings and weigh on the ETF’s performance.
WSML Top 10 Holdings
WSML’s story is driven by a handful of punchy small caps rather than any single giant. Rising energy names like Ovintiv and Permian Resources have been powering the fund lately, helped by steady strength from Royal Gold on the materials side. In health care, Guardant Health and Moderna are more volatile engines of growth, adding momentum but also some bumpiness, while Roku’s mixed tech performance keeps returns from feeling too smooth. Overall, the ETF leans into industrials, health care, and energy across developed markets, giving investors a globally diversified small-cap ride.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 MRNA | Moderna | 0.82% | $5.58M | $91.20B | 987.92% | 59Neutral |
 THC | Tenet Healthcare | 0.24% | $1.61M | $21.23B | 40.69% | 74Outperform |
 USFD | US Foods Holding | 0.23% | $1.55M | $21.93B | 49.79% | 74Outperform |
 VTRS | Viatris | 0.21% | $1.45M | $21.73B | 83.22% | 60Neutral |
 GH | Guardant Health | 0.19% | $1.31M | $23.48B | 71.78% | 61Neutral |
 ROKU | Roku | 0.20% | $1.36M | $23.91B | 53.41% | 65Neutral |
 WWD | Woodward | 0.19% | $1.26M | $19.64B | 26.07% | 79Outperform |
 RGLD | Royal Gold | 0.20% | $1.36M | $19.57B | 45.54% | 78Outperform |
 RBRK | Rubrik, Inc. Class A | 0.18% | $1.22M | $24.15B | 63.90% | 50Neutral |
 RVTY | Revvity | 0.17% | $1.15M | $18.24B | 73.88% | 67Neutral |
WSML Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For WSML, the sentiment is Positive. The current price of 34.71 is above the 20-day moving average (MA) of 34.01, above the 50-day MA of 34.46, and above the 200-day MA of 33.75, indicating a bullish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 57.11 is Neutral, neither overbought nor oversold. The STOCH value of 75.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for WSML.
WSML Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| WSML | $34.71 | $36.00(3.71% Upside) | $669.24M | 0.30% | 63Neutral |
 IQSI | $38.74 | $46.51(20.07% Upside) | $251.25M | 0.15% | 66Neutral |
 GDIV | $18.91 | $21.17(11.93% Upside) | $237.89M | 0.50% | 73Outperform |
 QWLD | $161.10 | $186.38(15.69% Upside) | $178.12M | 0.30% | 71Outperform |
 WLDR | $44.69 | $56.96(27.47% Upside) | $142.69M | 0.67% | 69Neutral |
 ESGG | $239.98 | $288.73(20.32% Upside) | $118.05M | 0.42% | 72Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| WSML | iShares MSCI World Small-Cap ETF | 34.71 | 5.67 | 19.54% | |
| IQSI | IQ Candriam ESG International Equity ETF | 38.74 | 5.52 | 16.63% | |
| GDIV | Harbor Dividend Growth Leaders ETF | 18.91 | 3.07 | 19.41% | |
| QWLD | SPDR MSCI World StrategicFactors ETF | 161.10 | 23.68 | 17.23% | |
| WLDR | Affinity World Leaders Equity ETF | 44.69 | 11.46 | 34.48% | |
| ESGG | Northern Trust Stoxx Global Esg Select Etf | 239.97 | 43.61 | 22.21% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.